Nec­tar Life­sciences hit with un­ti­tled let­ter over re­peat GMP is­sues at an­timi­cro­bial site

In­di­an API man­u­fac­tur­er Nec­tar Life­sciences late last month re­ceived an un­ti­tled let­ter from the FDA over re­peat GMP vi­o­la­tions, the FDA said, fol­low­ing a sev­en …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER